Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Bayer HealthCare
Woman and Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
Safety of Primovist / Eovist in Renally Impaired patients
The primary objective is to assess the magnitude of potential risk of developing NSF with the administration of Primovist/Eovist in patients with moderate to severe renal impairment for the developmen...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
Evaluation of the pharmacodynamic effect of the combination of Sildenafil and Riociguat on blood pressure and other safety parameters
To evaluate the effect of 1, 1.5, 2, and 2.5 mg riociguat tid (dose titration) administered simultaneously with sildenafil on blood pressure in subjects with symptomatic pulmonary arterial hypertensio...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
Double-blind, placebo controlled, randomized study of vardenafil to determine efficacy on Erectile Dysfunction (ED) in men with ED and Metabolic Syndrome ("ED-METABOLIC")
The objective of this study is to determine efficacy, tolerability and safety of vardenafil on Erectile Dysfunction (ED) in men with ED and Metabolic Syndrome.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
Phase Ib / II study of BAY 1000394 in combination with cisplatin / etoposide or carboplatin / etoposide as first-line therapy in subjects with extensive disease small cell lung cancer
Phase 1b: Safety, tolerability, pharmacokinetics, and maximum tolerated dose of BAY 1000394 in combination with cisplatin / etoposide or carboplatin / etoposide chemotherapy. Phase II: Response rate...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
A randomized, double-blind, double-dummy, multicenter, parallel group study to compare the tolerability and efficacy of once daily vardenafil versus vardenafil PRN versus placebo in men immediately after nerve-sparing prostatectomy for improving erectile function
The objective of this study is to compare the efficacy and safety of two modes of vardenafil therapy versus placebo to treat erectile dysfunction, starting within 14 days following bilateral nerve-spa...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Bayer HealthCare AG, D-51368 Leverkusen
Update Il y a 4 ans
A randomized, double blind, parallel group study of vardenafil flexible dose versus placebo in males with erectile dysfunction and their female partners’ sexual quality of life. PARTNER II
The primary objective of this study is to compare the efficacy of vardenafil flexible dose after 12 weeks of treatment versus placebo in terms of: 1. Success of maintenance of erection in men with ED....
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
Efficacy and safety of finerenone in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease
Demonstrate whether, in addition to standard of care (SoC), finerenone is superior to placebo in delaying the progression of kidney disease, as measured by the composite endpoint of time to first occu...
Country
None
organs
None
Specialty
None
unknown
More information
Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
Relative bioavailability of oral suspension of rivaroxaban compared to standard tablet
The primary objective of the study is to characterize the pharmacokinetics of 10 and 20 mg of rivaroxaban administered as an oral suspension in comparison to a 10 mg immediate release tablet. The pote...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
Controlled, Double-Blind, Randomized, Dose-ranging Study of once-daily regimen of BAY59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement-ODIXa-OD.HIP Study
The objective of this dose-ranging trial is to assess the efficacy and safety of BAY 59-7939 5 mg – 40 mg once daily dosing in prevention of VTE in men and in postmenopausal women aged 18 years or ab...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
Single-dose pilot study of oral rivaroxaban in pediatric subjects with venous thromboembolism
The primary objective of this study is to investigate pharmacokinetics and pharmacodynamics of single oral doses of rivaroxaban in paediatric subjects in order to obtain weight adjusted doses with equ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
4
5
6
7
8
9
10
11
12
13
Next